Makoto Kawase

25PUBLICATIONS
24CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPodiatryMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Sep 15, 2026
Correction: Iinuma et al. Utility of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Systemic Immune Inflammation Index as Prognostic, Predictive Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab and Ipilimumab. J. Clin. Med. 2021, 10, 5325.

|Feb 02, 2026
Prognostic Factors of Castration-Resistant Prostate Cancer Among Patients With Localized Prostate Cancer Who Underwent Robot-Assisted Radical Prostatectomy in a Retrospective Multicenter Japanese Cohort (MSUG94).

Takeshi Sasaki, Atsushi Igarashi, Shin Ebara

|Oct 01, 2025
Efficacy and Safety of Combination Androgen-Receptor Signaling Inhibitors, Denosumab, and Local Radiotherapy for Poly-Metastatic Prostate Cancer.

Makoto Kawase, Kota Kawase, Yuki Tobisawa

|Apr 25, 2025
Neoadjuvant Chemohormonal Therapy Versus Pelvic Lymphadenectomy on Biochemical Recurrence in Patients with High- or Very-High-Risk Prostate Cancer Undergoing Robot-Assisted Radical Prostatectomy.

Makoto Kawase, Satoshi Washino, Takato Nishino

|Mar 28, 2025
Low GCNT2/I-Branching Glycan Expression Is Associated with Bladder Cancer Aggressiveness.

Yuki Tobisawa, Keita Nakane, Takuya Koie

|Mar 26, 2025
Clinical predictors associated with prolonged pneumoperitoneum time in laparoscopic living donor nephrectomy.

Hiroki Kato, Keita Nakane, Ayaka Okamoto

Pageof 5

Frequent Collaborators

23 joint publications

Takuya Koie

12 joint publications

Koji Iinuma

9 joint publications

Keita Nakane

8 joint publications

Tomoki Taniguchi